- £761.85m
- £706.40m
- $176.36m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 81.9 | 102 | 131 | 149 | 176 |
Cost of Revenue | |||||
Gross Profit | 66.2 | 83.9 | 107 | 122 | 145 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 105 | 111 | 156 | 165 | 177 |
Operating Profit | -23 | -9.08 | -24.2 | -16 | -0.618 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -22.6 | -12.9 | -26.6 | -15 | -1.94 |
Provision for Income Taxes | |||||
Net Income After Taxes | -22.7 | -12.3 | -25.9 | -14.6 | 7.11 |
Net Income Before Extraordinary Items | |||||
Net Income | -22.7 | -12.3 | -25.9 | -14.6 | 7.11 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -22.7 | -12.3 | -25.9 | -14.6 | 7.11 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.055 | -0.029 | -0.064 | -0.035 | 0.016 |
Dividends per Share |